Abstract 2961: Developing ADC-resistant tumor models for efficacy evaluation of next-generation anticancer therapies.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148640580
Cites:
Cited by:
Related to:
